Bottega Veneta appoints Romain Spitzer as CEO

Kering has appointed Romain Spitzer as Chief Executive Officer of Bottega Veneta, with the luxury executive set to take up the role on 1 September as the Italian fashion house enters its next phase of growth.

Bottega Veneta appoints Romain Spitzer as CEO
Source image: TheIndustry.fashion

Kering has appointed Romain Spitzer as Chief Executive Officer of Bottega Veneta, with the luxury executive set to take up the role on 1 September as the Italian fashion house enters its next phase of growth.

What happened

Spitzer joins from LVMH, where he most recently served as President and CEO of Fragrance Group LVMH Beauty, overseeing a portfolio of luxury brands.

Why it matters

He brings more than 30 years of international experience across fragrance, beauty and luxury, having previously held senior roles at Guerlain, Jean Paul Gaultier Parfums, Yves Saint Laurent Parfums and Parfums Christian Dior before joining LVMH in 2016.

Based in Milan, Spitzer will report directly to Kering CEO Luca de Meo and will join the group’s Executive Committee. He succeeds Bartomoleo Rongone, who stepped down earlier this year after six years to become CEO of Moncler.

In his new role, Spitzer will focus on strengthening Bottega Veneta’s global appeal, deepening relationships with customers and driving retail excellence across international markets.

This news brief is based on reporting published by TheIndustry.fashion on 2026-07-16. The original report is linked below.

Original source

TheIndustry.fashion

https://www.theindustry.fashion/bottega-veneta-appoints-romain-spitzer-as-ceo/

This independent news brief is based on the public source identified above. It is an original summary or translation, not a reproduction of the source article. Rights in source text, research, trademarks and images remain with their respective owners; images are used under the licence or permission identified in the credit. Rights holders may contact rights@goodproductasia.com with evidence of ownership. Verified concerns will be corrected, replaced or removed promptly. This report is not investment, legal, medical or purchasing advice.